Cytokinetics Stock Forward View
| CYTK Stock | USD 65.04 1.68 2.65% |
Cytokinetics Stock outlook is based on your current time horizon. Although Cytokinetics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Cytokinetics' systematic risk associated with finding meaningful patterns of Cytokinetics fundamentals over time.
As of now the rsi of Cytokinetics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (1.57) | EPS Estimate Current Year (6.11) | EPS Estimate Next Year (6.07) | Wall Street Target Price 89.9444 | EPS Estimate Current Quarter (1.63) |
Using Cytokinetics hype-based prediction, you can estimate the value of Cytokinetics from the perspective of Cytokinetics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cytokinetics using Cytokinetics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cytokinetics using crowd psychology based on the activity and movement of Cytokinetics' stock price.
Cytokinetics Short Interest
An investor who is long Cytokinetics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Cytokinetics and may potentially protect profits, hedge Cytokinetics with its derivative instruments, or be ready for some potential downside.
200 Day MA 48.9568 | Short Percent 0.1419 | Short Ratio 6.08 | Shares Short Prior Month 13.8 M | 50 Day MA 63.638 |
Cytokinetics Relative Strength Index
The Naive Prediction forecasted value of Cytokinetics on the next trading day is expected to be 63.60 with a mean absolute deviation of 1.16 and the sum of the absolute errors of 70.80.Cytokinetics Hype to Price Pattern
Investor biases related to Cytokinetics' public news can be used to forecast risks associated with an investment in Cytokinetics. The trend in average sentiment can be used to explain how an investor holding Cytokinetics can time the market purely based on public headlines and social activities around Cytokinetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cytokinetics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cytokinetics.
Cytokinetics Implied Volatility | 1.18 |
Cytokinetics' implied volatility exposes the market's sentiment of Cytokinetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytokinetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytokinetics stock will not fluctuate a lot when Cytokinetics' options are near their expiration.
The Naive Prediction forecasted value of Cytokinetics on the next trading day is expected to be 63.60 with a mean absolute deviation of 1.16 and the sum of the absolute errors of 70.80. Cytokinetics after-hype prediction price | USD 63.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cytokinetics | Build AI portfolio with Cytokinetics Stock |
Prediction based on Rule 16 of the current Cytokinetics contract
Based on the Rule 16, the options market is currently suggesting that Cytokinetics will have an average daily up or down price movement of about 0.0738% per day over the life of the 2026-05-15 option contract. With Cytokinetics trading at USD 65.04, that is roughly USD 0.048 . If you think that the market is fully incorporating Cytokinetics' daily price movement you should consider acquiring Cytokinetics options at the current volatility level of 1.18%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Cytokinetics Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cytokinetics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cytokinetics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cytokinetics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cytokinetics' open interest, investors have to compare it to Cytokinetics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cytokinetics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cytokinetics. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Cytokinetics Additional Predictive Modules
Most predictive techniques to examine Cytokinetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytokinetics using various technical indicators. When you analyze Cytokinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cytokinetics Cash Forecast
To forecast cash or other financial indicators, analysts must employ diverse statistical methods, techniques, and algorithms. This approach allows them to detect underlying patterns in the Cytokinetics' financial statements, predicting their influence on future market prices.
Cash | First Reported 2002-12-31 | Previous Quarter 74.9 M | Current Value 225.5 M | Quarterly Volatility 45.4 M |
Cytokinetics Naive Prediction Price Forecast For the 11th of February 2026
Given 90 days horizon, the Naive Prediction forecasted value of Cytokinetics on the next trading day is expected to be 63.60 with a mean absolute deviation of 1.16, mean absolute percentage error of 2.05, and the sum of the absolute errors of 70.80.Please note that although there have been many attempts to predict Cytokinetics Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cytokinetics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cytokinetics Stock Forecast Pattern
| Backtest Cytokinetics | Cytokinetics Price Prediction | Research Analysis |
Cytokinetics Forecasted Value
In the context of forecasting Cytokinetics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cytokinetics' downside and upside margins for the forecasting period are 61.10 and 66.11, respectively. We have considered Cytokinetics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Cytokinetics stock data series using in forecasting. Note that when a statistical model is used to represent Cytokinetics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.8299 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.1606 |
| MAPE | Mean absolute percentage error | 0.0182 |
| SAE | Sum of the absolute errors | 70.797 |
Predictive Modules for Cytokinetics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cytokinetics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cytokinetics After-Hype Price Density Analysis
As far as predicting the price of Cytokinetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cytokinetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cytokinetics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cytokinetics Estimiated After-Hype Price Volatility
In the context of predicting Cytokinetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cytokinetics' historical news coverage. Cytokinetics' after-hype downside and upside margins for the prediction period are 60.88 and 65.90, respectively. We have considered Cytokinetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cytokinetics is very steady at this time. Analysis and calculation of next after-hype price of Cytokinetics is based on 3 months time horizon.
Cytokinetics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cytokinetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytokinetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cytokinetics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 2.51 | 0.01 | 0.00 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
65.04 | 63.39 | 0.05 |
|
Cytokinetics Hype Timeline
Cytokinetics is currently traded for 65.04. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.0. Cytokinetics is anticipated to increase in value after the next headline, with the price projected to jump to 63.39 or above. The average volatility of media hype impact on the company the price is over 100%. The price upswing on the next news is projected to be 0.05%, whereas the daily expected return is currently at 0.01%. The volatility of related hype on Cytokinetics is about 9821.74%, with the expected price after the next announcement by competition of 65.04. The company reported the previous year's revenue of 18.47 M. Net Loss for the year was (589.53 M) with loss before overhead, payroll, taxes, and interest of (318.05 M). Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Historical Fundamental Analysis of Cytokinetics to cross-verify your projections.Cytokinetics Related Hype Analysis
Having access to credible news sources related to Cytokinetics' direct competition is more important than ever and may enhance your ability to predict Cytokinetics' future price movements. Getting to know how Cytokinetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cytokinetics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NUVL | Nuvalent | 2.76 | 9 per month | 2.41 | 0.04 | 4.10 | (3.90) | 17.72 | |
| ABVX | Abivax SA American | (1.66) | 10 per month | 3.43 | 0.06 | 6.94 | (6.09) | 29.38 | |
| AXSM | Axsome Therapeutics | 5.12 | 12 per month | 1.33 | 0.12 | 4.20 | (2.46) | 26.78 | |
| RYTM | Rhythm Pharmaceuticals | (7.94) | 11 per month | 2.88 | (0.02) | 4.76 | (5.07) | 18.69 | |
| HALO | Halozyme Therapeutics | 0.39 | 10 per month | 1.67 | 0.09 | 3.72 | (2.83) | 9.83 | |
| MTSR | Metsera Common Stock | (0.13) | 8 per month | 2.40 | 0.17 | 14.25 | (4.09) | 75.60 | |
| JAZZ | Jazz Pharmaceuticals PLC | 0.91 | 8 per month | 1.65 | 0.07 | 3.66 | (3.14) | 25.96 | |
| CORT | Corcept Therapeutics Incorporated | 2.48 | 7 per month | 0.00 | (0.07) | 6.49 | (8.51) | 58.23 | |
| CRSP | Crispr Therapeutics AG | (2.16) | 9 per month | 0.00 | (0.06) | 5.51 | (5.47) | 19.81 |
Other Forecasting Options for Cytokinetics
For every potential investor in Cytokinetics, whether a beginner or expert, Cytokinetics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cytokinetics Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cytokinetics. Basic forecasting techniques help filter out the noise by identifying Cytokinetics' price trends.Cytokinetics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytokinetics stock to make a market-neutral strategy. Peer analysis of Cytokinetics could also be used in its relative valuation, which is a method of valuing Cytokinetics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cytokinetics Market Strength Events
Market strength indicators help investors to evaluate how Cytokinetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytokinetics shares will generate the highest return on investment. By undertsting and applying Cytokinetics stock market strength indicators, traders can identify Cytokinetics entry and exit signals to maximize returns.
Cytokinetics Risk Indicators
The analysis of Cytokinetics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cytokinetics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cytokinetics stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.15 | |||
| Semi Deviation | 2.24 | |||
| Standard Deviation | 2.58 | |||
| Variance | 6.67 | |||
| Downside Variance | 5.29 | |||
| Semi Variance | 5.01 | |||
| Expected Short fall | (2.49) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cytokinetics
The number of cover stories for Cytokinetics depends on current market conditions and Cytokinetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytokinetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytokinetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cytokinetics Short Properties
Cytokinetics' future price predictability will typically decrease when Cytokinetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytokinetics often depends not only on the future outlook of the potential Cytokinetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytokinetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 112 M | |
| Cash And Short Term Investments | 1.1 B |
Check out Historical Fundamental Analysis of Cytokinetics to cross-verify your projections. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. Projected growth potential of Cytokinetics fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytokinetics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (6.30) | Revenue Per Share | Quarterly Revenue Growth 3.181 | Return On Assets | Return On Equity |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cytokinetics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytokinetics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cytokinetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.